Stocks
Chugai Pharmaceutical Co., Ltd.CHGCY
PNKHealthcareBiotechnology$20.76-0.71%
Price as of · delayed, not real-time
A leading Japanese pharmaceutical firm specializing in research, development, and commercialization of innovative drugs, particularly in oncology and rare diseases. Investors monitor its pipeline and partnerships with global pharma giants like Roche.
Market Cap: $96.0B52W Range: $20.08-$34.84
Congressional Interest in Chugai Pharmaceutical Co., Ltd. (CHGCY)
6 members of Congress have disclosed 20 trades in Chugai Pharmaceutical Co., Ltd. (CHGCY), a Healthcare company. The buy/sell breakdown shows 9 purchases versus 11 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
20
Unique Politicians
6
Buys
9
Sells
11
Who in Congress Is Trading CHGCY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-04-09 | Josh Gottheimer | sell | $1K-$15K |
| 2024-06-21 | Josh Gottheimer | sell | $1K-$15K |
| 2024-04-04 | Josh Gottheimer | sell | $1K-$15K |
| 2024-04-04 | Josh Gottheimer | sell | $1K-$15K |
| 2023-08-18 | Josh Gottheimer | buy | $1K-$15K |
| 2023-07-10 | Daniel Goldman | sell | $1K-$15K |
| 2023-03-31 | Daniel Goldman | sell | $15K-$50K |
| 2023-02-27 | Daniel Goldman | buy | $1K-$15K |
| 2021-02-17 | Peter Meijer | sell | $15K-$50K |
| 2020-04-14 | Greg Gianforte | sell | $50K-$100K |
| 2020-04-13 | Josh Gottheimer | sell | $1K-$15K |
| 2020-01-13 | Greg Gianforte | buy | $15K-$50K |
| 2019-06-24 | Donna Shalala | sell | $1K-$15K |
| 2019-03-01 | Greg Gianforte | buy | $100K-$250K |
| 2019-02-21 | Donna Shalala | buy | $1K-$15K |
| 2019-02-20 | Josh Gottheimer | buy | $1K-$15K |
| 2019-02-20 | Donna Shalala | buy | $1K-$15K |
| 2019-02-19 | Josh Gottheimer | buy | $1K-$15K |
| 2019-02-19 | Donna Shalala | buy | $1K-$15K |
| 2018-12-17 | JAMES B. RENACCI | sell | $50K-$100K |